|
1
|
Rochette L, Guenancia C, Gudjoncik A,
Hachet O, Zeller M, Cottin Y and Vergely C:
Anthracyclines/trastuzumab: New aspects of cardiotoxicity and
molecular mechanisms. Trends Pharmacol Sci. 36:326–348. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Butany J, Ahn E and Luk A: Drug-related
cardiac pathology. J Clin Pathol. 62:1074–1084. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Piegari E, De Angelis A, Cappetta D, Russo
R, Esposito G, Costantino S, Graiani G, Frati C, Prezioso L,
Berrino L, et al: Doxorubicin induces senescence and impairs
function of human cardiac progenitor cells. Basic Res Cardiol.
108:3342013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Du WW, Yang W, Chen Y, Wu ZK, Foster FS,
Yang Z, Li X and Yang BB: Foxo3 circular RNA promotes cardiac
senescence by modulating multiple factors associated with stress
and senescence responses. Eur Heart J. 38:1402–1412. 2017.
|
|
5
|
Oliveira MS, Carvalho JL, Campos ACDA,
Gomes DA, de Goes AM and Melo MM: Doxorubicin has in vivo
toxicological effects on ex vivo cultured mesenchymal stem cells.
Toxicol Lett. 224:380–386. 2014. View Article : Google Scholar
|
|
6
|
Ezquer F, Gutiérrez J, Ezquer M, Caglevic
C, Salgado HC and Calligaris SD: Mesenchymal stem cell therapy for
doxorubicin cardiomyopathy: Hopes and fears. Stem Cell Res Ther.
6:1162015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang F, Chen H, Liu Y, Yin K, Wang Y, Li
X, Wang G, Wang S, Tan X, Xu C, et al: Doxorubicin caused apoptosis
of mesenchymal stem cells via p38, JNK and p53 pathway. Cell
Physiol Biochem. 32:1072–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Capasso S, Alessio N, Squillaro T, Di
Bernardo G, Melone MA, Cipollaro M, Peluso G and Galderisi U:
Changes in autophagy, proteasome activity and metabolism to
determine a specific signature for acute and chronic senescent
mesenchymal stromal cells. Oncotarget. 6:39457–39468. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miller EJ, Li J, Leng L, McDonald C,
Atsumi T, Bucala R and Young LH: Macrophage migration inhibitory
factor stimulates AMP-activated protein kinase in the ischaemic
heart. Nature. 451:578–582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu X, Pacheco BD, Leng L, Bucala R and Ren
J: Macrophage migration inhibitory factor plays a permissive role
in the maintenance of cardiac contractile function under starvation
through regulation of autophagy. Cardiovasc Res. 99:412–421. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Tong C, Yan X, Yeung E, Gandavadi
S, Hare AA, Du X, Chen Y, Xiong H, Ma C, et al: Limiting cardiac
ischemic injury by pharmacological augmentation of macrophage
migration inhibitory factor-AMP-activated protein kinase signal
transduction. Circulation. 128:225–236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohta S, Misawa A, Fukaya R, Inoue S,
Kanemura Y, Okano H, Kawakami Y and Toda M: Macrophage migration
inhibitory factor (MIF) promotes cell survival and proliferation of
neural stem/progenitor cells. J Cell Sci. 125:3210–3220. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Palumbo S, Tsai TL and Li WJ: Macrophage
migration inhibitory factor regulates AKT signaling in hypoxic
culture to modulate senescence of human mesenchymal stem cells.
Stem Cells Dev. 23:852–865. 2014. View Article : Google Scholar
|
|
14
|
Xia W, Zhang F, Xie C, Jiang M and Hou M:
Macrophage migration inhibitory factor confers resistance to
senescence through CD74-dependent AMPK-FOXO3a signaling in
mesenchymal stem cells. Stem Cell Res Ther. 6:822015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xia W, Xie C, Jiang M and Hou M: Improved
survival of mesenchymal stem cells by macrophage migration
inhibitory factor. Mol Cell Biochem. 404:11–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Okada M, Kim HW, Matsu-ura K, Wang YG, Xu
M and Ashraf M: Abrogation of age-induced MicroRNA-195 rejuvenates
the senescent mesenchymal stem cells by reactivating telomerase.
Stem Cells. 34:148–159. 2016. View Article : Google Scholar :
|
|
17
|
De Angelis A, Piegari E, Cappetta D, Russo
R, Esposito G, Ciuffreda LP, Ferraiolo FA, Frati C, Fagnoni F,
Berrino L, et al: SIRT1 activation rescues doxorubicin-induced loss
of functional competence of human cardiac progenitor cells. Int J
Cardiol. 189:30–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuilman T, Michaloglou C, Mooi WJ and
Peeper DS: The essence of senescence. Genes Dev. 24:2463–2479.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Falco E, Carnevale R, Pagano F,
Chimenti I, Fianchini L, Bordin A, Siciliano C, Monticolo R,
Equitani F, Carrizzo A, et al: Role of NOX2 in mediating
doxorubicin-induced senescence in human endothelial progenitor
cells. Mech Ageing Dev. 159:37–43. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ghosh AK, Rai R, Park KE, Eren M, Miyata
T, Wilsbacher LD and Vaughan DE: A small molecule inhibitor of
PAI-1 protects against doxorubicin-induced cellular senescence:
Molecular basis. Oncotarget. 7:72443–72457. 2016.PubMed/NCBI
|
|
21
|
Ho JH, Chen YF, Ma WH, Tseng TC, Chen MH
and Lee OK: Cell contact accelerates replicative senescence of
human mesenchymal stem cells independent of telomere shortening and
p53 activation: roles of Ras and oxidative stress. Cell Transplant.
20:1209–1220. 2011. View Article : Google Scholar
|
|
22
|
Liu WH, Liu JJ, Wu J, Zhang LL, Liu F, Yin
L, Zhang MM and Yu B: Novel mechanism of inhibition of dendritic
cells maturation by mesenchymal stem cells via interleukin-10 and
the JAK1/STAT3 signaling pathway. PLoS One. 8:e554872013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hou M, Cui J, Liu J, Liu F, Jiang R, Liu
K, Wang Y, Yin L, Liu W and Yu B: Angiopoietin-like 4 confers
resistance to hypoxia/serum deprivation-induced apoptosis through
PI3K/Akt and ERK1/2 signaling pathways in mesenchymal stem cells.
PLoS One. 9:e858082014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) μethod. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Crepin T, Carron C, Roubiou C, Gaugler B,
Gaiffe E, Simula- Faivre D, Ferrand C, Tiberghien P, Chalopin JM,
Moulin B, et al: ATG-induced accelerated immune senescence:
Clinical implications in renal transplant recipients. Am J
Transplant. 15:1028–1038. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the Human
Development Index (2008–2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Horie T, Ono K, Nishi H, Nagao K,
Kinoshita M, Watanabe S, Kuwabara Y, Nakashima Y, Takanabe-Mori R,
Nishi E, et al: Acute doxorubicin cardiotoxicity is associated with
miR-146a-induced inhibition of the neuregulin-ErbB pathway.
Cardiovasc Res. 87:656–664. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Volkova M and Russell R III: Anthracycline
cardiotoxicity: Prevalence, pathogenesis and treatment. Curr
Cardiol Rev. 7:214–220. 2011. View Article : Google Scholar
|
|
29
|
Franco VI, Henkel JM, Miller TL and
Lipshultz SE: Cardiovascular effects in childhood cancer survivors
treated with anthracyclines. Cardiol Res Pract. 2011:1346792011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fan GC, Zhou X, Wang X, Song G, Qian J,
Nicolaou P, Chen G, Ren X and Kranias EG: Heat shock protein 20
interacting with phosphorylated Akt reduces doxorubicin-triggered
oxidative stress and cardiotoxicity. Circ Res. 103:1270–1279. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fisher PW, Salloum F, Das A, Hyder H and
Kukreja RC: Phosphodiesterase-5 inhibition with sildenafil
attenuates cardiomyocyte apoptosis and left ventricular dysfunction
in a chronic model of doxorubicin cardiotoxicity. Circulation.
111:1601–1610. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Piegari E, Russo R, Cappetta D, Esposito
G, Urbanek K, Dell'Aversana C, Altucci L, Berrino L, Rossi F and De
Angelis A: MicroRNA-34a regulates doxorubicin-induced
cardiotoxicity in rat. Oncotarget. 7:62312–62326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Y, Liang X, Liao S, Wang W, Wang J,
Li X, Ding Y, Liang Y, Gao F, Yang M, et al: Potent paracrine
effects of human induced pluripotent stem cell-derived mesenchymal
atem xells attenuate doxorubicin-induced cardiomyopathy. Sci Rep.
5:112352015. View Article : Google Scholar
|
|
34
|
Mao C, Hou X, Wang B, Chi J, Jiang Y,
Zhang C and Li Z: Intramuscular injection of human umbilical
cord-derived mesenchymal stem cells improves cardiac function in
dilated cardiomyopathy rats. Stem Cell Res Ther. 8:182017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Z, Xu K, Bi Y, Yu G, Wang S, Qi X
and Zhong H: Low intensity ultrasound promotes the sensitivity of
rat brain glioma to Doxorubicin by down-regulating the expressions
of p-glucoprotein and multidrug resistance protein 1 in vitro and
in vivo. PLoS One. 8:e706852013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Baugh JA, Chitnis S, Donnelly SC, Monteiro
J, Lin X, Plant BJ, Wolfe F, Gregersen PK and Bucala R: A
functional promoter polymorphism in the macrophage migration
inhibitory factor (MIF) gene associated with disease severity in
rheumatoid arthritis. Genes Immun. 3:170–176. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma H, Wang J, Thomas DP, Tong C, Leng L,
Wang W, Merk M, Zierow S, Bernhagen J, Ren J, et al: Impaired
macrophage migration inhibitory factor (MIF)-AMPK activation and
ischemic recovery in the senescent heart. Circulation. 122:282–292.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Maity A and Koumenis C: HIF and MIF - a
nifty way to delay senescence? Genes Dev. 20:3337–3341. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ibrahim MX, Sayin VI, Akula MK, Liu M,
Fong LG, Young SG and Bergo MO: Targeting isoprenylcysteine
methylation ameliorates disease in a mouse model of progeria.
Science. 340:1330–1333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li W, Croce K, Steensma DP, McDermott DF,
Ben-Yehuda O and Moslehi J: Vascular and metabolic implications of
novel targeted cancer therapies: Focus on kinase inhibitors. J Am
Coll Cardiol. 66:1160–1178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hang P, Zhao J, Sun L, Li M, Han Y, Du Z
and Li Y: Brain-derived neurotrophic factor attenuates
doxorubicin-induced cardiac dysfunction through activating Akt
signalling in rats. J Cell Mol Med. 21:685–696. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Henson SM, Lanna A, Riddell NE, Franzese
O, Macaulay R, Griffiths SJ, Puleston DJ, Watson AS, Simon AK,
Tooze SA, et al: p38 signaling inhibits mTORC1-independent
autophagy in senescent human CD8+ T cells. J Clin
Invest. 124:4004–4016. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Finkel T and Holbrook NJ: Oxidants,
oxidative stress and the biology of ageing. Nature. 408:239–247.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee KH, Cho H, Lee S, Woo JS, Cho BH, Kang
JH, Jeong YM, Cheng XW and Kim W: Enhanced-autophagy by exenatide
mitigates doxorubicin-induced cardiotoxicity. Int J Cardiol.
232:40–47. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sobierajski J, Hendgencotta U, Luedike P,
Rammos C, Bernhagen J, Kelm M and Rassaf T: Time dependent
regulation of MIF by S-nitros(yl)ation reduces apoptosis in
myocardial I/R-injury. Eur Heart J. 31:S18–S19. 2013.
|
